Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Synchronous and metachronous extrapelvic metastases of cancer of the cervix: a study of prognosis and palliation
1Departments of Radiology, USA
2Biometry, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
*Corresponding Author(s): F. L. AMPIL E-mail:
Thirty-eight women with cancer of the cervix and extrapelvic metastases (EPM) were retrospectively reviewed with respect to prognosis and responses to palliative radiotherapy. Seventeen patients had synchronous EPM and 21 individuals displayed metachronous metastatic disease outside of the pelvic cavity. A meaningful difference was not revealed (p = 0.11) in the comparison of the two groups' 2-year survival rates. However, this small retrospective review highlighted the efficacy of radiotherapy administered for palliation to this cohort of patients.
Extrapelvic metastases; Cervical cancer
F. L. AMPIL,G. Caldito. Synchronous and metachronous extrapelvic metastases of cancer of the cervix: a study of prognosis and palliation. European Journal of Gynaecological Oncology. 2002. 23(4);291-292.
[1] Arai T., Nakamo T.. Morita S., Sakashita K., Nakamura Y. K., Fukuhisa K.: "High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix: a 20-year experience". Cancer, 1992, 69, 175.
[2] Blythe J. G.. Ptacek J. J.. Buchsbaum H. J., Latourette H. B.: "Bony metastases from carcinoma of cervix: Occurrence, diagnosis, and treatment". Cancer, 1975, 36, 475.
[3] Jones W. B.. Shingleton H. M., Russell A. et al.: "Patterns of care for invasive cervical cancer". Cancer, 1995, 76, 1934.
[4] Matsuyama T., Tsukamoto N., Imachi M., Nakano H.: "Bone metastasis from cervix cancer". Gynecol. Oneal.,1989, 32, 72.
[5] Bell M. C., Davidson S. A., Mathis J. M., Ampil F.: "Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trial". Gynecol. Oncol., 2001, 80, 128.
[6] Carlson V., Delclos L., Fletcher G. H.: "Distant metastases in squamous-cell carcinoma of the uterine cervix". Am. J. Roentgenol., 1967, 88, 961.
[7] Plentl A. A., Friedman E. A.: "Clinical significance of cervical lymphatics". In: Lymphatic System of the Female Genitalia. Plentl A. A., Friedman E. A., eds., Philadelphia: W. B. Saunders, 1971, 95.
[8] DeEulis T. G., Markoe A. M., Sedlacek T. V.. Brady L. W.: "The influence of hematogenous and serosal metastases on advanced (FIGO IIA-IYB) squamous cell carcinoma of the cervix". Am. J. Clin.Oncol., 1987, 10, 10.
[9] Fagundes H., Perez C. A., Grigsby P. W.. Lockett M. A.: "Distant metastases after irradiation alone in carcinoma of the uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1992, 24, 197.
[10] Choy D., Wong L. C., Sham J., Ngan H. Y. S., Ma H.K.: "Dose tumor response for carcinoma of cervix: an analysis of 594 patients treated by radiotherapy". Gynecol. Oncol., 1993, 49, 311.
[11] Upadhyay S. K., Symonds R. P., Haelterman M., Watson E. R.: 'The treatment of stage IV carcinoma of cervix by radical dose radiotherapy". Radiother. Oncol., 1988, 11, 15.
[12] Berman M. L.,K eys H.,C reasman W.,D iSaia P.,B undy B.,B iessing J.: "Survival and patterns of recurrence in cervical cancer metas tatic to periaortic lymph nodes". Gynecol. Oncol., 1984, 19, 8.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top